» Articles » PMID: 21962440

The Roles of Cyclic Nucleotide Phosphodiesterases (PDEs) in Steroidogenesis

Overview
Specialty Pharmacology
Date 2011 Oct 4
PMID 21962440
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The second messenger, cAMP, is one of the most important regulatory signals for control of steroidogenesis. This review focuses on current knowledge about regulation of cyclic nucleotides by phosphodiesterases (PDEs) in steroidogenic tissues. The first PDE known to directly regulate steroidogenesis was PDE2, the cGMP-stimulated PDE. PDE2 mediates ANP/cGMP-induced decreases in aldosterone production. Recently, the PDE8 family has been shown to control steroidogenesis in two tissues. Specifically, PDE8A regulates testosterone production by itself and in concert with additional IBMX-sensitive PDEs. PDE8B modulates basal corticosterone synthesis via acute and chronic mechanisms. In addition to cAMP-dependent pathways, cGMP signaling also can promote steroidogenesis, and PDE5 modulates this process. Finally, PDE mutations may lead to several human diseases characterized by abnormal steroid levels.

Citing Articles

Study on gene expression in the liver at various developmental stages of human embryos.

Chen H, Li T, Cai M, Huang Z, Gao J, Ding H Front Cell Dev Biol. 2025; 12():1515524.

PMID: 39845086 PMC: 11751009. DOI: 10.3389/fcell.2024.1515524.


Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptor's anti-inflammatory effects.

Stoicovy R, Cora N, Perez A, Nagliya D, Del Calvo G, Lopez T Inflamm Res. 2024; 73(11):2043-2056.

PMID: 39305297 DOI: 10.1007/s00011-024-01950-0.


Single-cell transcriptomic analysis identifies downregulated phosphodiesterase 8B as a novel oncogene in IDH-mutant glioma.

He Z, Peng Y, Wang D, Yang C, Zhou C, Gong B Front Immunol. 2024; 15:1427200.

PMID: 38989284 PMC: 11233524. DOI: 10.3389/fimmu.2024.1427200.


Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesis.

Ariyeloye S, Kammerer S, Klapproth E, Wielockx B, El-Armouche A Pflugers Arch. 2024; 476(9):1383-1398.

PMID: 38355819 PMC: 11310285. DOI: 10.1007/s00424-024-02921-4.


Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases.

Gambaryan S, Mohagaonkar S, Nikolaev V Front Endocrinol (Lausanne). 2023; 14:1239492.

PMID: 37674612 PMC: 10478253. DOI: 10.3389/fendo.2023.1239492.


References
1.
Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin K . A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet. 2006; 38(7):794-800. DOI: 10.1038/ng1809. View

2.
Lakics V, Karran E, Boess F . Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology. 2010; 59(6):367-74. DOI: 10.1016/j.neuropharm.2010.05.004. View

3.
Conti M, Beavo J . Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem. 2007; 76:481-511. DOI: 10.1146/annurev.biochem.76.060305.150444. View

4.
Horvath A, Mericq V, Stratakis C . Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med. 2008; 358(7):750-2. DOI: 10.1056/NEJMc0706182. View

5.
Spiessberger B, Bernhard D, Herrmann S, Feil S, Werner C, Luppa P . cGMP-dependent protein kinase II and aldosterone secretion. FEBS J. 2009; 276(4):1007-13. DOI: 10.1111/j.1742-4658.2008.06839.x. View